PMID: 6736395Apr 1, 1984

Lymphocytic vasculitis: is it a specific clinicopathologic entity?

Journal of Cutaneous Pathology
M C Massa, W P Su

Abstract

Seventy-one biopsy specimens taken at the Mayo Clinic from June 1977 through May 1981 demonstrated lymphocytic vasculitis. All specimens met the criteria for lymphocytic vasculitis, defined as (1) a predominantly lymphocytic infiltrate that involves and surrounds blood vessel walls, (2) fibrinoid necrosis of blood vessel walls, and (3) endothelial cell hyperplasia. Other histologic findings such as thrombosis, extravasation of erythrocytes, ulceration, epidermal infarction, and evidence of nuclear dust were seen only occasionally. Hypocomplementemia and other serologic abnormalities were very rare, even when lymphocytic vasculitis was extensive. The clinical diagnoses varied, with drug reaction (12 patients) and chronic urticaria (10 patients) being most frequent. In 32 cases, no specific diagnosis could be made at the time of dermatologic dismissal. In the remaining 39 cases, the diagnoses were varied and no definite clinical categories can be applied to them. We also observed typical lymphocytic vasculitis in some cases of other clinical entities, such as nodular scabies, erythema multiforme, and urticarial vasculitis, and so forth. We conclude that lymphocytic vasculitis is probably not a specific clinicopathologic entity bu...Continue Reading

References

Apr 1, 1997·Clinical Reviews in Allergy & Immunology·I DeclevaE Berti
Aug 1, 1989·Journal of the American Academy of Dermatology·S LeeS Lee
Jun 14, 2002·International Journal of Radiation Oncology, Biology, Physics·Luis F Fajardo L-GAlbert E Raizner
Dec 11, 1999·Clinics in Dermatology·I GhersetichT Lotti
Oct 13, 2009·Clinical Neuropharmacology·Jarmila SzilasiováPeter Bohus
Apr 24, 2014·American Journal of Clinical Dermatology·Megan R GoeserDavid A Wetter
Aug 11, 2007·Current Rheumatology Reports·Antonio Iglesias-GamarraEric L Matteson
Feb 1, 1990·Mayo Clinic Proceedings·L E Gibson
Oct 1, 1991·Journal of the American Academy of Dermatology·K V RatnamM S Peters
Nov 12, 1998·Journal of the American Academy of Dermatology·T LottiJ L Jorizzo
May 4, 2004·Immunology and Allergy Clinics of North America·Mark D P Davis, Jerry D Brewer
May 27, 2004·Leukemia & Lymphoma·Mine CabukErtan Ozdemir
Jun 1, 1990·The Journal of Dermatology·S I ChunS Lee
Jul 11, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·G K PatelR Marks
Aug 24, 2000·The Australasian Journal of Dermatology·S Kossard
Jan 20, 1999·The British Journal of Dermatology·P Jarrett, J Snow
Oct 1, 1986·Journal of Cutaneous Pathology·W P SuF C Powell
Oct 1, 1989·Journal of Cutaneous Pathology·S I ChunR S Rogers
Jun 1, 1988·International Journal of Dermatology·N Tosca, J D Stratigos
Sep 1, 1996·The British Journal of Dermatology·A M FarrellJ J Cream

Citations

Jun 1, 1976·The Journal of Investigative Dermatology·N A SoterK F Austen
Jan 1, 1979·Seminars in Thrombosis and Hemostasis·R L Bick
May 1, 1979·Human Pathology·F G MullickJ J Fenoglio
Nov 1, 1977·The Journal of Investigative Dermatology·R G GowerH N Claman

Related Concepts

Vasculitis
Necrosis
Urticarial Vasculitis
Extravasation
Hypocomplementaemia
Lymphoid Cells
Erythema Multiforme
Differential Diagnosis
Bikinia le-testui
Fibrinoid Necrosis

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

International Journal of Dermatology
T LottiI Ghersetich
The American Journal of Dermatopathology
Philip E LeBoit
© 2020 Meta ULC. All rights reserved